The weekly litigation news digest is live. Subscribe now

IP Verse

Combined Pharmaceutical Composition - EP3030262

The patent EP3030262 was granted to Cytune Pharma on Oct 9, 2019. The application was originally filed on Aug 8, 2014 under application number EP14761281A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3030262

CYTUNE PHARMA
Application Number
EP14761281A
Filing Date
Aug 8, 2014
Status
Opposition Rejected
Feb 24, 2023
Publication Date
Oct 9, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MARGARET DIXONJul 9, 2020MEWBURN ELLIS -

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2009002562
INTERNATIONAL-SEARCH-REPORTWO2012175222
OPPOSITIONEP130039647
OPPOSITIONEP3030262
OPPOSITIONWO2007046006
OPPOSITIONWO2009002562
OPPOSITIONWO2012175222
OPPOSITIONWO2015018529

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents